Quarterly report pursuant to Section 13 or 15(d)

Nature of Business (Details Narrative)

v3.20.2
Nature of Business (Details Narrative) - USD ($)
1 Months Ended 6 Months Ended
Apr. 02, 2020
Mar. 27, 2020
Feb. 07, 2020
Jan. 30, 2020
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
May 04, 2017
Proceeds from merger         $ (5,411,745)    
Price per share $ 0.34       $ 0.17      
Cash balance         $ 4,201,405      
Restricted cash         1,250,336   $ 336  
Working capital deficit         14,420,828      
Proceeds from loan         $ 2,689,450    
Debt instrument interest rate 10.00%       8.00% 8.00%   8.00%
Debt instrument monthly interest and principal payments       $ 585        
PPP Loan [Member]                
Proceeds from loan   $ 2,100,000            
Debt instrument interest rate   1.00%            
Debt instrument maturity date   Apr. 30, 2022            
Debt instrument monthly interest and principal payments   $ 119,000            
Securities Purchase Agreement [Member] | Convertible Preferred Stock: Series 2 [Member] | Common Stock [Member]                
Preferrred stock conversion     1,426,854          
Securities Purchase Agreement [Member] | Convertible Preferred Stock: Series 2 [Member] | Maximum [Member]                
Shares issued during the period new issues, shares     1,500          
Shares issued during the period new issues     $ 1,500,000          
Shares issuing period description     The transaction occurred in two closings, the first of which, for 1,000 shares, occurred in mid-February 2020, and the second of which, for 500 shares, occurred in March 2020.          
Sonnet BioTherapeutics, Inc [Member]                
Proceeds from merger $ 6,000,000              
Price per share $ 0.01              
Warrant issued upon merger description Amergent received proceeds from Sonnet of $6,000,000 as well as a warrant to purchase 2% of the outstanding common shares of Sonnet (186,161 shares) for $0.01 per share ("Merger Consideration").              
Warrant to purchase shares of common stock 186,161